CIK 0001613780 · Non-accelerated filer<br>Smaller reporting company
DBV Technologies S.A.
Sign in to watch- Ticker
- DBVTF
- Exchange
- Nasdaq, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- France
- Entity type
- operating
- Phone
- 330155427878
- Business address
- 107 AVENUE DE LA REPUBLIQUE, CHATILLON, France
Securities
- DBVT American Depositary Shares Nasdaq
- DBVTF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-27 | BAKER BROS. ADVISORS LP Director | Grant or award · First Pre-Funded Warrant | +2,299,656 | 2,299,656 | ||
| 2025-03-27 | BAKER BROS. ADVISORS LP Director | Grant or award · First Pre-Funded Warrant | +25,005,240 | 25,005,240 | ||
| 2025-03-27 | BAKER BROS. ADVISORS LP Director | Grant or award · BS Warrant | +2,299,656 | 2,299,656 | ||
| 2025-03-27 | BAKER BROS. ADVISORS LP Director | Grant or award · BS Warrant | +25,005,240 | 25,005,240 | ||
| 2025-01-30 | Mohideen Pharis Chief Medical Officer | Sale | −600 | $0.85 | $510 | 110,510 |
| 2024-12-04 | Tasse Daniel CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +813,200 | 813,200 | ||
| 2024-11-25 | Mohideen Pharis Chief Medical Officer | Sale | −565 | $0.57 | $322 | 111,110 |
| 2024-11-22 | Mohideen Pharis Chief Medical Officer | Sale | −342 | $0.53 | $181 | 111,675 |
| 2024-11-21 | Mohideen Pharis Chief Medical Officer | Grant or award | +35,000 | 114,367 | ||
| 2024-11-21 | Mohideen Pharis Chief Medical Officer | Sale | −2,350 | $0.54 | $1K | 112,017 |
| 2024-11-21 | Mohideen Pharis Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +215,000 | 215,000 | ||
| 2024-11-21 | Boucinha Virginie Chief Financial Officer | Grant or award | +19,000 | 38,000 | ||
| 2024-11-21 | Boucinha Virginie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +113,000 | 113,000 | ||
| 2024-07-29 | Mohideen Pharis Chief Medical Officer | Sale | −1,785 | $0.98 | $2K | 79,367 |
| 2024-05-24 | Mohideen Pharis Chief Medical Officer | Sale | −660 | $1.36 | $898 | 81,152 |
| 2024-05-22 | Mohideen Pharis Chief Medical Officer | Sale | −382 | $1.38 | $527 | 81,812 |
| 2024-03-08 | Tasse Daniel CHIEF EXECUTIVE OFFICER | Purchase | +17,094 | $0.83 | $14K | 17,094 |
| 2024-02-06 | Ndu Adora Director | Purchase | +1,825 | $0.89 | $2K | 1,825 |
| 2023-11-22 | Mohideen Pharis Chief Medical Officer | Sale | −2,245 | $1.74 | $4K | 82,194 |
| 2023-11-20 | Boucinha Virginie Chief Financial Officer | Grant or award | +19,000 | 19,000 |
Page 2 of 4 · 70 trades